Bioxytran BIXT
OTC BIXT
$0.02 +0.00 (+0.00%)
At close: Oct 19, 2026 · 4:00 PM EDT

Bioxytran (BIXT) Long-Term Debt Repayments (2010 - 2020)

Updated

Bioxytran (BIXT) posted Long-Term Debt Repayments of $232,948 for FY2020, down 6.8% from $250,000 in FY2019.

Analysis

Bioxytran (BIXT) Long-Term Debt Repayments (2010 - 2020) Analysis & Trends

Since FY2011, Bioxytran has reported Long-Term Debt Repayments for 6 years.

  • Annual Long-Term Debt Repayments shows a five-year compound annual growth rate of 110.2% (FY2015 to FY2020).
  • The FY2020 figure stands as the lowest annual Long-Term Debt Repayments since FY2015.
  • Business Quant data shows BIXT's Long-Term Debt Repayments at $250,000 in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 873.00 Mn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 1.00 Mn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 2.00 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 5.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 20.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 2.46 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 17.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Bioxytran 2.29 Mn 1.13 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2020 232,948.00
Dec 31, 2015 -6,500.00
Sep 30, 2015 10,675.00
Mar 31, 2014 6,000.00
Jun 30, 2013 12,000.00
Mar 31, 2013 -7,000.00
Dec 31, 2011 -6,251.00
Sep 30, 2011 5,000.00
Mar 31, 2011 17,132.00
Dec 31, 2010 -10,000.00
Sep 30, 2010 10,000.00
API Access

Bioxytran Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=BIXT&period=max&api_key=YOUR_API_KEY